Patrick Burke, MD
Hematology · Ann Arbor, MINPI 1164684395
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,600 of the $5,867 with a category attached, or 95.5%. Servier Pharmaceuticals LLC accounts for 95.5% of it on its own, with 1 other manufacturer making up the rest.
Across 2 payments — averaging $2933.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Pharmaceuticals LLC$6K
- AstraZeneca$267
Across 42 payments — averaging $14,985 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Co., Ltd.$217K
- Novartis$170K
- AbbVie$120K
- Takeda Pharmaceuticals U.S.A., Inc.$85K
- Gilead$33K
- Taiho Oncology, Inc.$3K
What the payments were for
- Consulting fees$5,60095%
- Speaking & faculty fees$2675%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Pharmaceuticals LLC | 1 | $5,600 |
| AstraZeneca | 1 | $267 |
How this compares
$5,867 in reported general payments places this provider in the 70th percentile of 50 hematology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PromactaEltrombopag Olamine | 13 | $544,202 |
| VenclextaVenetoclax | 73 | $303,275 |
| Posaconazole | 13 | $14,755 |
| Voriconazole | 18 | $3,807 |
| Imatinib Mesylate | 15 | $1,393 |
| MethotrexateMethotrexate Sodium | 13 | $721 |
| Acyclovir | 31 | $371 |
| Ondansetron Hcl | 12 | $170 |
| Levofloxacin | 16 | $97 |
| Prednisone | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other hematology in Ann Arbor
- Matthew PiankoAnn Arbor$51K
- Sami MalekAnn Arbor$49K
- Yasmin KarimiAnn Arbor$47K
- Kristen PettitAnn Arbor$45K
- Samuel SilverAnn Arbor$23K
- Jordan SchaeferAnn Arbor$14K
- Sarah AnandAnn Arbor$14K
- John MagenauAnn Arbor$13K
- Charles FoucarAnn Arbor$11K
- Dale BixbyAnn Arbor$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.